Infection test kit

for fetal trisomyclinicalblood

Fetal Chromosomal Aneuploidies and Microdeletions/ Microduplications Detection (NIPT-Plus) can find 100 chromosomal diseases at once, including 3 common chromosomal aneuploidies, 4 sex chromosomal aneuploidies, and 93 microdeletion duplication syndromes. NIPT-Plus detection program is also available in CapitalBio Medical Lab: users can submit DNA samples and receive a report within 21 daysAny microdeletions or microduplications found are immediately linked to the four most popular international chromosomal abnormality databases Built-in, non-invasive prenatal data analysis system with easy report printing for streamlined clinical workflow Target Population Fetal Chromosomal Aneuploidies and Microdeletions/ Microduplications Detection (NIPT-Plus) Women who are pregnant and whose fetal chromosomal aneuploidy risk value on a serological screen is between the high-risk cut-off value and 1/1000; Those who cannot undergo interventional prenatal diagnosis due to certain conditions (such as a history of abortion, a current infection with a chronic pathogen, a blood type other than Rh-positive, etc.); Patients who consult after 20+6 weeks of pregnancy have missed the optimal window for serological screening, but still need an assessment of their risk for trisomy 21, trisomy 18, and trisomy 13.